August 18, 2017 / 12:37 PM / 10 months ago

BRIEF-Champions Oncology to collaborate with Addario Lung Cancer Medical Institute

* Champions Oncology announces research collaboration with the Addario Lung Cancer Medical Institute to develop unique cohort of patient-derived xenograft (PDX) models

* Champions Biotechnology - deal with Addario Lung Cancer Medical Institute “ALCMI” to develop a cohort of PDX models in patients with ROS1 gene rearrangement​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below